
Tenth Annual Controversies in Hematologic Malignancies Virtual Symposium
This one-day symposium will raise and address the most challenging questions in current clinical practice for hematologic malignancy. Topics will include management of myelodysplastic syndromes, management of myeloproliferative neoplasms, germline/hereditary myeloid malignancy syndromes, immunotherapy update in myeloma, AL amyloidosis, managing transplant ineligible myeloma patients, relapsed refractory DLBCL, NHL cellular therapies and updates in mantle cell lymphoma treatment.
Target Audience
Physicians, Physician Assistants, Nurse Practitioners, Registered Nurses and Allied Health Professionals
Learning Objectives
The aim of this conference is to highlight major controversies in the treatment of hematological malignancies. At the completion of this activity, attendees will be able to make therapeutic decisions based on the available data, realizing the ongoing debate in those areas.
8:00-8:05am | Introduction
Myeloid Malignancy Block
8:05-8:25am | Updates in the Management of Myelodysplastic Syndromes - Guru Subramanian Guru Murthy, MD, MS
8:25-8:45am | Updates in the Management of Myeloproliferative Neoplasms - Laura Michaelis, MD
8:45-9:05am | Hereditary Myeloid Malignancy Disorders: For Whom, Why & How in 2021 - Jane Churpek, MD
9:05-9:20am | Myeloid Malignancy Panel Discussion - All Speakers
9:20-9:35am | Break
Plasma Cell Disorder Block
9:35-9:55am | Immunotherapy Updates in Myeloma - Saurabh Chhabra, MD, MS
9:55-10:15am | Recent Advances in the Treatment of AL Amyloidosis Updates - Suzanne Lentzsch, MD, PhD
10:15-10:35am | How to Manage Transplant Ineligible Myeloma Patients - Meera Mohan, MD
10:35-10:50am | Plasma Cell Disorder Panel Discussion - All Speakers
10:50-11:05am | Break
Lymphoma Block
11:05-11:25am | Updates in New Therapies in Relapsed Refractory DLBCL - Suma Devata, MD
11:25-11:45am | Selecting Optimal Cell-Based Therapy in Relapsed/Refractory DLBCL - Mehdi Hamadani, MD
11:45am -12:05pm | Updates in Mantle Cell Lymphoma - Timothy Fenske, MD, MS
12:05-12:20pm | Lymphoma Panel Discussion - All Speakers
12:20pm | Adjourn
This event will be held virtually. A link will be sent in the weeks proceeding the symposium. At the conclusion of the event, attendees will be follow a link to log into Ethos to complete an evaluation and claim their CME.
Guest Speakers
Jane Churpek, MD, MS
Assistant Professor
Division of Hematology, Oncology and Palliative Care
University of Wisconsin School of Medicine and Public Health
Suzanne Lentzsch, MD, PhD
Department of Medicine
Division of Hematology/Oncology
Director, Multiple Myeloma & Amyloidosis Program
Columbia University
Herbert Irving Comprehensive Cancer Center
Froedtert and the Medical College of Wisconsin Speakers
Saurabh Chhabra, MD, MS
Associate Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
Associate Professor of Medicine
Professor of Medicine
Mehdi Hamadani, MD
Professor of Internal Medicine
Division of Hematology & Oncology
Medical College of Wisconsin
Laura Michaelis, MD
Associate Professor of Medicine
Division of Hematology & Oncology
Medical College of Wisconsin
Meera Mohan, MD, MS, FACP
Instructor
Division of Hematology & Oncology
Medical College of Wisconsin
Guru Subramanian Guru Murthy, MD, MS
Assistant Professor of Medicine
Division of Hematology & Oncology
Medical College of Wisconsin
Planning Committee
Sameem Abedin, MD
Co-Program Director
Assistant Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
Lyndsey Runaas, MD
Co-Program Director
Assistant Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
Dan Bullock
Education Program Coordinator
Division of Hematology and Oncology
Medical College of Wisconsin
Catherine Sestito, APNP
Nurse Practitioner
Division of Hematology and Oncology
Medical College of Wisconsin
All persons in control of content have NO relevant financial relationships to dislose with the exception of:
Name | Company | Role |
---|---|---|
Guru Subramanian Guru Murthy, MD, MS | Cardinal Health Cancer Expert Now | Advisory Board Speaking |
Jane Churpek, MD | UpToDate, Inc. | Author |
Timothy Fenske, MD | Genentech. Adaptive Biotechnologies, AbbVie, Verastem, Kite MorphoSys Seattle Genetics, AstraZeneca,Celgene, Adaptive Biotechnologies Millennium, Kyowa. TG Therapeutics, Portola, Curis | Consultant Speaking Research Funding |
Mehdi Hamadani, MD | Incyte, Celgene, ADC Therapeutics Takeda, Otsuka Pharmaceutical, Spectrum Pharmaceuticals, Astellas | Consultant Research Funding |
Laura Michaelis, MD | Wintrobe's Publishing & American Society of Hematology Jazz Pharmaceuticals | Editor Research Funding |
Suzanne Lentzsch, MD | Karyopharm, Sanofi Genzyme Magenta, Kadman, Bion Tech, Caelum Bioscience Sorrento, Janssen, Celularity, AbbVie, GSK, Takeda, Ossium | Research Funding Investor Consultant |
In accordance with the ACCME® standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 3.75 hours of participation for continuing education for allied health professionals.
Nurse Practitioners:
Medical College of Wisconsin, Inc. is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners: AANP Provider Number XXXXXX. This program has been approved for 3.75 contact hours of continuing education (which includes 0.75 hours of pharmacology).
Available Credit
- 3.75 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 3.75 Hours of ParticipationHours of Participation credit.
- 0.75 NP PharmacologyNP Pharmacology credit.
- 3.75 NP Contact Hours